Use of natural killer cells as immunotherapy for leukaemia
- 30 September 2008
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 21 (3) , 467-483
- https://doi.org/10.1016/j.beha.2008.07.008
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- The unexpected effect of cyclosporin A on CD56+CD16− and CD56+CD16+ natural killer cell subpopulationsBlood, 2007
- Inhibitory KIR–HLA receptor–ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphomaBritish Journal of Cancer, 2007
- A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immatureBlood, 2007
- Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCTBlood, 2007
- Tumoricidal activity of TLR7/8-activated inflammatory dendritic cellsThe Journal of Experimental Medicine, 2007
- Donor–Recipient Combinations of Group A and B KIR Haplotypes and HLA class I Ligand Affect the Outcome of HLA-Matched, Sibling Donor Hematopoietic Cell TransplantationHuman Immunology, 2007
- Identification of bidirectional promoters in the human KIR genesGenes & Immunity, 2007
- Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cellsBlood, 2006
- Evidence for discrete stages of human natural killer cell differentiation in vivoThe Journal of Experimental Medicine, 2006
- HLA expression in uveal melanoma: there is no rule without some exceptionHuman Immunology, 2002